 NEWARK, N.J., Oct. 6, 2021 PRNewswire -- Rafael Holdings, Inc., NYSE: RFL, a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its Barer Institute and investment in Rafael Pharmaceuticals, Inc., announced today the appointment of Mary Margaret Mimi Huizinga, MD, MPH as Chief Development and Medical Officer, effective October 18, 2021. 